Literature DB >> 6171678

Comparison of hemodynamic effects of furosemide and piretanide in normovolemic patients.

H Valette, J L Hebert, B Raffestin, A Lockhart, E Apoil.   

Abstract

The effects of furosemide and piretanide (Hoe 118) on the pulmonary hemodynamics in 20 patients recovering from uncomplicated myocardial infarctions were compared in a double-blind study. The diuretic effects and half-lives of the two drugs were not significantly different, so that their hemodynamic actions could be compared directly. Both drugs progressively reduced cardiac output and pressures in the pulmonary circulation, whereas systemic vascular resistance increased significantly. Both drugs slightly increased pulmonary blood volume but not significantly. Total blood volume decreased less rapidly than cardiac output, so that the ratio of cardiac output to total blood volume decreased with time. We conclude that both drugs increase venous compliance in normovolemic subjects and probably increase the compliance of pulmonary vessels.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6171678     DOI: 10.1097/00005344-198003000-00002

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  7 in total

Review 1.  Central hemodynamic effects of diuretic therapy in chronic heart failure.

Authors:  B Silke
Journal:  Cardiovasc Drugs Ther       Date:  1993-01       Impact factor: 3.727

Review 2.  Haemodynamic effects of diuretics in heart failure.

Authors:  E B Raftery
Journal:  Br Heart J       Date:  1994-08

Review 3.  Diuretics. Clinical pharmacology and therapeutic use (Part I).

Authors:  A Lant
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

4.  Acute haemodynamic effects of a single intravenous dose of piretanide in congestive heart failure.

Authors:  H Valette; J L Hébert; E Apoil
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 5.  Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

6.  Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure--a placebo-controlled trial.

Authors:  W Haerer; U Bauer; N Sultan; K Cernoch; N Mouselimis; K J Fehske; M Hetzel; M Stauch; V Hombach
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

7.  Piretanide, a potassium stable diuretic, in the treatment of essential hypertension.

Authors:  M Verho; B Rangoonwala; W Dols; U Fratzer; J Kaczynski; W Mühlhäusler
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.